The linked editorial from JAMA Neurology cites IMPACT-AD, the course co-led by UCI MIND, and work by The 90+ Study investigators, Maria Corrada, ScM, ScD and Claudia Kawas, MD. The…
Lee mas
Noticias
On June 28–29, 2021, the National Academies of Sciences, Engineering, and Medicine held a virtual workshop, “Behavioral and Social Research and Clinical Practice Implications of Biomarkers and Other Preclinical Diagnostics…
Lee mas
Panel of experts from around the nation to give updates on what is the third leading cause of death in Orange County. UCI MIND and Alzheimer’s Orange County will host…
Lee mas
Join Orange County Aging Services Collaborative on Sept 24th from anywhere! This conference is meant for older adults and those who support them. Family, friends, professionals, general public, community, and…
Lee mas
The National Institute on Aging has online health information in Spanish for older adults and caregivers on more than 60 topics related to healthy aging, caregiving, and Alzheimer’s disease and related…
Lee mas
❓How will #aducanumab’s approval influence people’s willingness to join, and stay in, future Alzheimer’s disease #clinicaltrials? UCI MIND Director Joshua Grill, PhD was recently quoted by Alzforum discussing this topic.…
Lee mas
Karen Zagorski of the Institute for Molecular Medicine in Huntington Beach presented data on a line of research conducted in collaboration with UCI MIND’s David Cribbs, Hayk Davtyan, and Matt…
Lee mas
NIA-supported scientists have developed a new mouse model that produces a form of the human beta-amyloid protein, a hallmark of Alzheimer’s disease. An important research tool, mouse models enable the…
Lee mas
The UCI Health commercial “Journey” won an Emmy Award in the Commercial – Single Spot category from the National Academy of Television Arts & Science-Pacific Southwest Chapter. “Congratulations to the…
Lee mas
The post María M. Corrada, ScM, ScD at AAIC 2021 appeared first on UCI MIND.
Lee mas
The post UCI MIND Director speaks on AAIC panel about impact and ethics of Aduhelm approval appeared first on UCI MIND.
Lee mas
UCI MIND professor, David Sultzer, MD, and other investigators show a clinical benefit of an investigational antipsychotic drug, pimavanserin in reducing behavioral symptoms related to Alzheimer’s disease. The post David…
Lee mas
For the 21st consecutive year, U.S. News & World Report has recognized UCI Medical Center as one of America’s Best Hospitals. The annual rankings recognize hospitals that excel in treating the most…
Lee mas
UCI MIND researcher, Dr. Vivek Swarup is gaining significant attention for his work on glial cell gene expression in AD. His lab’s research, published in Nature Genetics 2 weeks ago…
Lee mas
Sept. 10th Virtual Alzheimer’s Research Conference #AlzAngles: Dr. Thomas Lane will discuss the impact of viral infections, like COVID-19, on Alzheimer’s disease. Register for free: https://conference.mind.uci.edu/register The post Sept. 10th…
Lee mas
Contributed by Joshua Grill, PhD UCI MIND Director Joshua Grill, PhD co-authored an article in Nature Reviews Neurology about the FDA’s decision on Aduhelm. Read more on this below: Since…
Lee mas
UCI School of Biological Sciences Dean Frank LaFerla is co-senior author of a study involving a new genetically engineered mouse model that, unlike its predecessors, is based on the most…
Lee mas
UCI Medical Center has been awarded the American Heart Association’s Comprehensive Hypertension Center Certification for its commitment to following proven, research-based treatment guidelines to care for people with complex or…
Lee mas
A new study published in JAMA Network saw a reduction of COVID-19 infection rates among healthcare personnel at UCI Health after receiving the COVID-19 vaccine. By mid-April, there were 133 million…
Lee mas
Contributed by Vivek Swarup, PhD The brain is made up of billions of cells that are tightly coordinated in complex neural circuitry and are ultimately responsible for manifesting our memories,…
Lee mas